Differential effect of intranasally administrated kinin B₁ and B₂ receptor antagonists in Alzheimer’s disease mice

References

Adami, C., Bianchi, R., Pula, G., and Donato, R. (2004). S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochim. Biophys. Acta 1742, 169–177.10.1016/j.bbamcr.2004.09.008Search in Google Scholar

Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., Cooper, N.R., Eikelenboom, P., Emmerling, M., Fiebich, B.L., et al. (2000). Inflammation and Alzheimer’s disease. Neurobiol. Aging 21, 383–421.10.1016/S0197-4580(00)00124-XSearch in Google Scholar

Beattie, E.C., Stellwagen, D., Morishita, W., Bresnahan, J.C., Ha, B.K., Von Zastrow, M., Beattie, M.S., and Malenka, R.C. (2002). Control of synaptic strength by glial TNFα. Science 295, 2282–2285.10.1126/science.1067859Search in Google Scholar PubMed

Bernardino, L., Agasse, F., Silva, B., Ferreira, R., Grade, S., and Malva, J.O. (2008). Tumor necrosis factor-α modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures. Stem. Cells 26, 2361–2371.10.1634/stemcells.2007-0914Search in Google Scholar PubMed

Bicca, M.A., Costa, R., Loch-Neckel, G., Figueiredo, C.P., Medeiros, R., and Calixto, J.B. (2015). B₂ receptor blockage prevents Aβ-induced cognitive impairment by neuroinflammation inhibition. Behav. Brain Res. 278: 482–491.Search in Google Scholar

Blaukat, A. (2003). Structure and signalling pathways of kinin receptors. Andrologia 35, 17–23.10.1046/j.1439-0272.2003.00533.xSearch in Google Scholar PubMed

Boche, D., Perry, V.H., and Nicoll, J.A. (2013). Review: activation patterns of microglia and their identification in the human brain. Neuropathol. Appl. Neurobiol. 39, 3–18.10.1111/nan.12011Search in Google Scholar PubMed

Calixto, J.B., Medeiros, R., Fernandes, E.S., Ferreira, J., Cabrini, D.A., and Campos, M.M. (2004). Kinin B₁ receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br. J. Pharmacol. 143, 803–818.10.1038/sj.bjp.0706012Search in Google Scholar PubMed PubMed Central

Chao, J., Chao, L., Swain, C.C., Tsai, J., and Margolius, H.S. (1987). Tissue kallikrein in rat brain and pituitary: regional distribution and estrogen induction in the anterior pituitary. Endocrinology 120, 475–482.10.1210/endo-120-2-475Search in Google Scholar PubMed

El Khoury, J. and Luster, A.D. (2008). Mechanisms of microglia accumulation in Alzheimer’s disease: therapeutic implications. Trends Pharmacol. Sci. 29, 626–632.10.1016/j.tips.2008.08.004Search in Google Scholar PubMed

Gate, D., Rezai-Zadeh, K., Jodry, D., Rentsendorj, A., and Town, T. (2010). Macrophages in Alzheimer’s disease: the blood-borne identity. J. Neural Transm. 117, 961–970.10.1007/s00702-010-0422-7Search in Google Scholar PubMed PubMed Central

Groger, M., Lebesgue, D., Pruneau, D., Relton, J., Kim, S.W., Nussberger, J., and Plesnila, N. (2005). Release of bradykinin and expression of kinin B₂ receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 25, 978–989.10.1038/sj.jcbfm.9600096Search in Google Scholar

Hall, J.M. (1992). Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther. 56, 131–190.10.1016/0163-7258(92)90016-SSearch in Google Scholar

Hall, J.M. (1997). Bradykinin receptors. Gen. Pharmacol. 28, 1–6.10.1016/S0306-3623(96)00174-7Search in Google Scholar

Hanson, L.R. and Frey, W.H. 2nd, (2008). Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 9 (Suppl 3), S5.10.1186/1471-2202-9-S3-S5Search in Google Scholar PubMed PubMed Central

Hickman, S.E., Allison, E.K., and El Khoury, J. (2008). Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer’s disease mice. J. Neurosci. 28, 8354–8360.10.1523/JNEUROSCI.0616-08.2008Search in Google Scholar PubMed PubMed Central

Holscher, C. (2014). First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer’s disease. Alzheimer’s Dementia 10, S33–37.10.1016/j.jalz.2013.12.006Search in Google Scholar PubMed

Koppal, T., Drake, J., Yatin, S., Jordan, B., Varadarajan, S., Bettenhausen, L., and Butterfield, D.A. (1999). Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer’s disease. J. Neurochem. 72, 310–317.10.1046/j.1471-4159.1999.0720310.xSearch in Google Scholar PubMed

Lacoste, B., Tong, X.K., Lahjouji, K., Couture, R., and Hamel, E. (2013). Cognitive and cerebrovascular improvements following kinin B₁ receptor blockade in Alzheimer’s disease mice. J. Neuroinflammation 10, 57.10.1186/1742-2094-10-57Search in Google Scholar PubMed PubMed Central

Lee, D.C., Rizer, J., Hunt, J.B., Selenica, M.L., Gordon, M.N., and Morgan, D. (2013). Review: experimental manipulations of microglia in mouse models of Alzheimer’s pathology: activation reduces amyloid but hastens tau pathology. Neuropathol. Appl. Neurobiol. 39, 69–85.10.1111/nan.12002Search in Google Scholar PubMed PubMed Central

Leeb-Lundberg, L.M., Marceau, F., Muller-Esterl, W., Pettibone, D.J., and Zuraw, B.L. (2005). International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27–77.10.1124/pr.57.1.2Search in Google Scholar PubMed

Levant, A., Levy, E., Argaman, M., and Fleisher-Berkovich, S. (2006). Kinins and neuroinflammation: dual effect on prostaglandin synthesis. Eur. J. Pharmacol. 546, 197–200.10.1016/j.ejphar.2006.06.074Search in Google Scholar

Mackaness, G.B. (1977). Cellular immunity and the parasite. Adv. Exp. Med. Biol. 93, 65–73.10.1007/978-1-4615-8855-9_5Search in Google Scholar

McGeer, P.L. and McGeer, E.G. (2015). Targeting microglia for the treatment of Alzheimer’s disease. Expert Opin. Ther. Targets 19, 497–506.10.1517/14728222.2014.988707Search in Google Scholar

Oakley, H., Cole, S.L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006). Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129–10140.10.1523/JNEUROSCI.1202-06.2006Search in Google Scholar

Passos, G.F., Medeiros, R., Cheng, D., Vasilevko, V., Laferla, F.M., and Cribbs, D.H. (2013). The bradykinin B1 receptor regulates Abeta deposition and neuroinflammation in Tg-SwDI mice. Am. J. Pathol. 182, 1740–1749.10.1016/j.ajpath.2013.01.021Search in Google Scholar

Prediger, R.D., Medeiros, R., Pandolfo, P., Duarte, F.S., Passos, G.F., Pesquero, J.B., Campos, M.M., Calixto, J.B., and Takahashi, R.N. (2008). Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer’s disease. Neuroscience 151, 631–643.10.1016/j.neuroscience.2007.11.009Search in Google Scholar

Raidoo, D.M. and Bhoola, K.D. (1998). Pathophysiology of the kallikrein-kinin system in mammalian nervous tissue. Pharmacol. Ther. 79, 105–127.10.1016/S0163-7258(98)00011-4Search in Google Scholar

Raslan, F., Schwarz, T., Meuth, S.G., Austinat, M., Bader, M., Renne, T., Roosen, K., Stoll, G., Siren, A.L., and Kleinschnitz, C. (2010). Inhibition of bradykinin receptor B₁ protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J. Cereb. Blood Flow Metab. 30, 1477–1486.10.1038/jcbfm.2010.28Search in Google Scholar PubMed PubMed Central

Regoli, D. and Barabe, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32, 1–46.Search in Google Scholar

Schror, K. (1992). Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors. J. Cardiovasc. Pharmacol. 20 (Suppl 9), S68–73.Search in Google Scholar

Schulze-Topphoff, U., Prat, A., Prozorovski, T., Siffrin, V., Paterka, M., Herz, J., Bendix, I., Ifergan, I., Schadock, I., Mori, M.A., et al., (2009). Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nat. Med. 15, 788–793.10.1038/nm.1980Search in Google Scholar PubMed PubMed Central

Scicli, A.G., Forbes, G., Nolly, H., Dujovny, M., and Carretero, O.A. (1984). Kallikrein-kinins in the central nervous system. Clin. Exp. Hypertens A 6, 1731–1738.10.3109/10641968409046068Search in Google Scholar PubMed

Sharma, J.N. (2014). Basic and clinical aspects of bradykinin receptor antagonists. Prog. Drug Res. 69, 1–14.10.1007/978-3-319-06683-7_1Search in Google Scholar

Singhal, G., Jaehne, E.J., Corrigan, F., Toben, C., and Baune, B.T. (2014). Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci. 8, 315.10.3389/fnins.2014.00315Search in Google Scholar

Stein, M., Keshav, S., Harris, N., and Gordon, S. (1992). Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287–292.10.1084/jem.176.1.287Search in Google Scholar

Streit, W.J. (2004). Microglia and Alzheimer’s disease pathogenesis. J. Neurosci. Res. 77, 1–8.10.1002/jnr.20093Search in Google Scholar

Torika, N., Filipovich-Rimon, T., Asraf, K., Roasso, E., Danon, A., and Fleisher-Berkovich, S. (2014). Differential regulation of astrocyte prostaglandin response by kinins: possible role for mitogen activated protein kinases. Eur. J. Pharmacol. 741, 323–329.10.1016/j.ejphar.2014.08.013Search in Google Scholar

Viel, T.A. and Buck, H.S. (2011). Kallikrein-kinin system mediated inflammation in Alzheimer’s disease in vivo. Curr. Alzheimer Res. 8, 59–66.10.2174/156720511794604570Search in Google Scholar

Walker, K., Perkins, M., and Dray, A. (1995). Kinins and kinin receptors in the nervous system. Neurochem. Int. 26, 1–16; discussion 17–26.10.1016/0197-0186(94)00114-ASearch in Google Scholar

Zipser, B.D., Johanson, C.E., Gonzalez, L., Berzin, T.M., Tavares, R., Hulette, C.M., Vitek, M.P., Hovanesian, V., and Stopa, E.G. (2007). Microvascular injury and blood-brain barrier leakage in Alzheimer’s disease. Neurobiol. Aging 28, 977–986.10.1016/j.neurobiolaging.2006.05.016Search in Google Scholar PubMed